Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
暂无分享，去创建一个
P. Pérez-Martínez | J. Ramos-Rincón | J. Ena | R. Gómez-Huelgas | M. Rubio-Rivas | L. Pérez-Belmonte | F. Fuentes-Jimenez | M. Ayala-Gutiérrez | J. Lecumberri | J. Torres-Peña | For the Cardiovascular Cell Therapy Research Network | M. Madrazo | M. López-Carmona | C. M. Pérez | L. J. Huerta | J. A. Muñoz | Begoña Cortés Rodríguez | Carlos-Jorge Ripper | F. Fuentes-Jiménez | Marcos Guzmán García | Beatriz Vicente Montes | J. Solà | R. Ferrer | Iris El Attar Acedo | S. P. Canteli | Sara Fuente Cosío | F. Martínez